Skip to content
SEARCH
Investing
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
Health
Entertainment
Real Estate
Cannabis
ESG
Financial
Industrials
Food & Beverage
Search
SEARCH FOR AN ARTICLE
Search
Search
Investing
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
Health
Entertainment
Real Estate
Cannabis
ESG
Financial
Industrials
Food & Beverage
SEARCH
Home
Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Biotechnology
Galmed Pharmaceuticals Shares Surge Nearly 150% After Phase 2B Study
June 12, 2018
LATEST NEWS
Investing
Analysts Adjust JPMorgan Stock Target Ahead of Investor Day
Investing
Novavax Stock Surge: Evaluating Its Potential Amidst Sanofi’s Collaboration
Investing
Nio Set to Debut First Mass-Market Car in May
Investing
Palantir Beats Sales Estimates, Raises Outlook with AI Boost
Investing
Amgen Stock Skyrockets on CEO’s Obesity Drug Progress Update